The specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products business has announced it will supply premium, GMP-certified formulated cannabis oil to XLR8 BRAZIL, a Rio de Janeiro based value-added distributor serving Brazil, Latin America’s largest medical cannabis market.
MediPharm Labs has completed commercial exports to Australia and has fully commercialized its Australian extraction facility, with MediPharm Labs Australia established in 2017.
Read more HERE
Sign up for the weekly ABCC newsletter
Back editions of the quarterly "Boletim Brazil" are available HERE